Pre-made Gilvetmab benchmark antibody ( Canine Whole mAb, anti-PDCD1 (Canine) therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Gilvetmab biosimilar, Canine Whole Mab: Anti-PDCD1 (Canine) therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-243-1mg	1mg	3090
GMP-Bios-ab-243-10mg	10mg	Inquiry
GMP-Bios-ab-243-100mg	100mg	Inquiry
GMP-Bios-ab-243-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Gilvetmab biosimilar, Canine Whole Mab: Anti-PDCD1 (Canine) therapeutic antibody
INN Name	Gilvetmab
Target	PDCD1 (Canine)
Format	Canine Whole mAb
Derivation	Caninized
Species Reactivity	Canine
CH1 Isotype	IgG2
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Unknown
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2016
Year Recommended	2017
Companies	Merck
Conditions Approved	na
Conditions Active	Canine Cancers
Conditions Discontinued	na
Development Tech	na